Diamond Hill Capital Management
AMAG

Diamond Hill Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Diamond Hill Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,260
Closed -$130K – 165
2019
Q3 		$130K Hold
11,260
– – ﹤0.01% 161
2019
Q2 		$112K Buy
+11,260
New +$121K ﹤0.01% 166

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Diamond Hill Capital Management's AMAG Position: Q4 2019 in Review

Diamond Hill Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2019, closing a stake of 11,260 shares — an estimated $130K sold.

Diamond Hill Capital Management first reported a position in AMAG in Q2 2019 and held it in 2 quarters. The position peaked at $130K in Q3 2019. 134 funds tracked by Wall St. Rank hold AMAG as of Q4 2019.

  • Diamond Hill Capital Management reported no remaining AMAG Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Diamond Hill Capital Management sold 11,260 AMAG Pharmaceuticals shares in Q4 2019, an estimated $130K.
  • Diamond Hill Capital Management first reported a position in AMAG Pharmaceuticals in Q2 2019 and held it in 2 quarters.
  • Diamond Hill Capital Management's AMAG Pharmaceuticals position peaked at $130K in Q3 2019.
  • 134 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2019.

Based on Diamond Hill Capital Management's 13F filing for Q4 2019, filed 7 Feb 2020.